重组痘病毒表达裂谷热病毒囊膜蛋白及其免疫原性分析

裂谷热(Rift valley fever,RVF)是由裂谷热病毒(Rift valley fever virus,RVFV)引起的烈性人畜共患传染病。囊膜糖蛋白G是病毒的主要结构蛋白,由基因组M节段编码,翻译后裂解为Gn和Gc,其中Gn为诱导中和抗体的主要免疫原。本研究分别构建了表达RVFV囊膜蛋白G(n c)和Gn的重组痘病毒rVV-G (n c)和rVV-Gn。SDS-PAGE、Western blot结果表明分子量分别为56 Ku(Gn)、58 Ku(Gc)左右的重组蛋白在rVV-G(n c)和rVV-Gn哺乳动物细胞获得准确表达[G(n c)裂解为Gn和Gc],并具有特异免疫反应原性。以rBac-G(n c)和rBac-Gn感染的昆虫细胞裂解物为包被抗原,间接ELISA检测血清抗体结果显示,rVV-G (n c)和rVV-Gn免疫小鼠可诱导显著的Gn、Gc特异抗体反应,并且rVV-G(n c)免疫诱导主要保护性免疫原Gn特异抗体反应效果优于rVV-Gn。结果表明,表达全长囊膜糖蛋白重组痘病毒rG(n c)具有作为安全有效的重组病毒活载体疫苗的潜力,为RVF重组亚单位疫苗的探索研究奠定了基础。     

裂谷热病毒Gn1蛋白在杆状病毒系统中的表达与纯化

采用杆状病毒表达系统表达并纯化裂谷热病毒(RVFV)Gn蛋白,并对其反应原性进行鉴定.根据GenBank公布的Gn蛋白的序列,选取其主要抗原区Gn1设计引物进行PCR扩增,将扩增产物克隆至pFastBac HTB载体,构建重组转移载体,并将其转化DH10Bac感受态细胞进行蓝白斑筛选.将鉴定正确的重组杆粒转染Sf9细胞...     

禽白血病病毒亚群重组囊膜蛋白基因的表达效果

用ELISA法测定了重组杆状病毒rBac-4817env感染的Sf9细胞中重组囊膜蛋白基因的表达效果。用特异性抗禽白血病病毒J型群（ALV-J）单克隆抗体JE9荧光染色证明了重组病毒能够在感染的Sf9细胞中表达ALV-J的env基因；糖基化抑制试验的结果表明，Sf9细胞表达的env基因产物是一种糖基化蛋白。不同量的重组病毒感染细胞与基因产物的表达产量无正相关，然而当每个细胞感染的病毒量2-800个时，表达产量相对较好。表达产物以感染后72-96h较高，并随着感染时间的延长，分泌到细胞外的重组基因产物有所增加，但在120h后，表达产物分解增加。研究结果对今后获取大量的基因的产物，并对其特性进一步研究奠定了基础。     

猪瘟病毒囊膜蛋白基因pcDNA4．0-E重组质粒的构建及其对小鼠的免疫原性

以猪瘟病毒石门株RNA序列为模板，应用RT—PCR方法，克隆得到猪瘟病毒囊膜蛋白E0-E2 cDNA全序列，并将其与真核表达质粒pcDNA4．0定向连接，构建了重组质粒pcDNA4．0-E。经提纯后，给试验组小鼠后肢胫前肌注射pcDNA4．0-E，每只100μg，15d后再注射1次，同时设空白对照组。于二免后第10、20、30d分别扑杀小鼠，进行免疫小鼠脾和外周血淋巴细胞的转化增殖试验，并用间接ELISA法检测血清抗体水平。结果显示，与空白对照组相比，所构建的重组质粒能够极显著增强小鼠脾细胞和外周血淋巴细胞的增殖（P〈0．01），血清抗体水平从二免后的第10d开始逐渐升高，且极显著高于对照组（P〈0．01）。说明该重组质粒能够诱导小鼠产生特异性免疫反应。     

利用重组杆状病毒表达口蹄疫病毒基因研究进展

杆状病毒表达系统是一种新型、高表达的真核表达系统,广泛应用在新疫苗、诊断试剂和新型蛋白药物开发研究方面。不少研究人员报道了利用重组杆状病毒表达口蹄疫病毒基因生产结构蛋白和非结构蛋白,期望表达的蛋白质具有与真实病毒蛋白相似的生物学活性,能够应用于候选疫苗或诊断检测抗原。作者对近几年利用重组杆状病毒表达口蹄疫结构蛋白基因和非结构蛋白基因的研究进展进行了综述,并提出相关问题和困难供商讨。     

裂谷热诊断技术研究进展

裂谷热(RVF)是由蚊传播的急性、以高热为特征的病毒性传染病,主要感染牛、羊等哺乳动物,也可感染人,被OIE列为A类疫病.虽然我国目前尚未发生RVF的报道,但近年来该病的分布范围有不断扩大的趋势.随着经济全球化的发展,RVF对我国的畜牧业以及人类的健康构成威胁.在国内没有报告RVF病例的情况下,国内对RVF的认识普遍不足,因此需要国境口岸加强对裂谷热进行检测和监测,防止RVF传入是必需的,为加强对裂谷热检测技术的认识,现对裂谷热诊断技术的研究进展进行综述.     

禽流感病毒核蛋白基因在重组杆状病毒中的表达

利用ＲＴ－ＰＣＲ方法成功地扩增了我国禽流感病毒分离株Ａ／Ｘｉｎｇｊｉａｎｇ／１／９６（Ｈ１４Ｎ５）的核蛋白（ＮＰ）基因,其限制性内切酶图谱和核苷酸序列与鸭源的标准Ｈ１４Ｎ５毒株几乎完全一致,与其它毒株则有较大差异,说明该鸡源分离株与鸭源毒株有非常近的亲缘关系。将ＮＰ基因定向克隆到杆状病毒转移载体ｐＶＬ１３９３中,再与杆状病毒线性ＤＮＡ（ＢＡＣ－Ｎ－ＢｌｕｅＤＮＡ）共转染于Ｓｆ９昆虫细胞中,经过三次蚀斑筛选,获得重组病毒ｒＢ２。用其细胞表达产物裂解后作ＳＤＳ－ＰＡＧＥ蛋白电泳、Ｗｅｓｔｅｒｎ－ｂｌｏｔ和ｄｏｔ－ＥＬＩＳＡ,结果表明ＮＰ基因在杆状病毒系统中获得了表达。同时用表达产物作琼脂扩散试验,结果表明表达产物与现行标准禽流感琼扩抗原具有相同的生物学活性。     

裂谷热诊断技术

裂谷热是节肢动物传播的急性、高热、病毒性动物传染病。病毒属于布尼病毒科,白蛉属。主要引起绵羊、山羊和牛的流产和新生畜死亡。其它动物易感性较低。人也易感。易感性随着年龄增加而明显降低,一周龄内绵羊和山羊死亡率     

应用重组杆状病毒表达NDVF糖蛋白和预防ND

用苜蓿银纹夜蛾核型多角体病毒（ＡｃＮＰＶ）和家蚕核型多体病毒（ＢｍＮＰＶ）构建的杂合杆状病毒表达了鸡新城疫病毒（ＮＤＶ）Ｄ２６株的融合（Ｆ）糖蛋白，将编码Ｆ蛋白的基因插入宿主范围扩展的改良杆状病毒表达载体，重组杆状病毒ＨｙＦ１２１感染的草地贪夜蛾（ｓｆ）细胞中，表达的Ｆ蛋白定位于细胞表面，ＨｙＦ１２１感染吞蛹后，用感染蚕蛹制取抗ＮＤＶ的亚单位疫苗，这种亚单位疫苗接种鸡后可抵抗ＮＤＶ强毒的攻击。     

Rift valley fever.

Rift Valley fever virus is an arthropod-borne Phlebovirus endemic in sub-Saharan Africa. Outbreaks also have occurred in Egypt, Madagascar, and most recently in the Arabian peninsula. Large epizootics occur at irregular intervals in seasons of above-average rainfall with persistent flooding and the appearance of large numbers of floodwater-breeding Aedine mosquitoes. The virus is transmitted transovarially and can remain dormant in mosquito eggs during dry interepizootic periods. Low-level virus circulation occurs in high-rainfall forested areas, although individual cases of the disease rarely are recognized. RVF is characterized by abortion in pregnant animals and a high mortality in newborn lambs, kids, and calves. Susceptibility to disease is related to age and breed, with severe disease occurring in the young of exotic sheep and cattle breeds. RVF is a zoonosis, and human beings experience an influenza-like illness and, more rarely, complications such as encephalitis or retinitis. The virus causes a severe hepatitis, particularly in aborted fetuses and newborn lambs. The disease must be differentiated from other conditions that cause death with hepatitis and jaundice. Both an inactivated and a live attenuated vaccine are available. New-generation vaccines are being tested, because the existing mousebrain-attenuated strain induces fetal teratology or abortion in a percentage of pregnant animals. Diagnosis is based on histopathology or the demonstration of viral antigen or antibody.     

猪瘟病毒Erns蛋白在杆状病毒系统中的表达及纯化

采用杆状病毒表达系统表达并纯化猪瘟病毒E^rns蛋白,并对其反应原性进行鉴定。将猪瘟病毒的E^rns 基因克隆至pFastbac-HT-A 载体上,构建了pFA-E^rns重组质粒;经转座、转染后构建重组杆状病毒rBac-E^rns;通过优化接毒时间和接毒量等参数,最终确定表达条件。将表达产物采用亲和层析法纯化后,采用Western Blotting 鉴定E^rns 蛋白的反应性,并采用间接ELISA 方法对其应用进行了初步探索。结果显示,获得了重组杆状病毒rBac-E^rns,经Western Blotting 和间接免疫荧光(IFA)鉴定,该重组病毒能够与猪瘟阳性血清和E^rns 单抗发生特异性反应。纯化后的E^rns 蛋白纯度较好,浓度为0. 2 mg/ mL,经Western Blotting 方法鉴定证明,纯化后的蛋白与E^rns单抗和猪瘟阳性血清能够发生特异性反应;初步建立了间接ELISA 方法检测猪瘟抗体,证明表达的蛋白可以区分猪瘟阳性血清和阴性血清。表明本研究利用杆状病毒表达系统成功表达并纯化了猪瘟病毒E^rns蛋白,纯化后的E^rns蛋白具有良好的反应性,可以作为开发鉴别诊断试剂的备选蛋白以及用于E^rns 蛋白的结构和生物学功能研究。     

Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo

Wild ruminants are thought to serve as natural hosts for Rift Valley fever virus (RVFV) but the role of these animals as reservoirs for RVFV during inter-epidemic periods and as amplifiers during epidemics is not well understood. An indirect enzyme-linked immunoassay (I-ELISA) based on the recombinant nucleocapsid protein (rNp) of RVFV was validated for the detection of specific IgG antibodies in African buffalo. Data sets derived from testing buffalo sera from Kenya (n=405) and South Africa (n=618) were dichotomised according to the results of a virus neutralisation test. The assay characteristic performance was analysed using threshold values optimised by the two-graph receiver operating characteristics (TG-ROC) analysis, and by mean plus two, as well as by mean plus three standard deviations derived from I-ELISA PP values in uninfected animals. Among 1023 buffalo sera tested, 77 (7.5%) had detectable virus neutralising antibodies. The assay had high intra- and inter-plate repeatability in routine runs. At a cut-off optimised by the TG-ROC at 95% accuracy level, the diagnostic sensitivity of the I-ELISA was 98.7% and diagnostic specificity 99.36% while estimates for the Youden's index (J) and efficiency (Ef) were 0.98 and 99.31%. When cut-off values determined by traditional statistical approaches were used, the diagnostic sensitivity was 100% but estimates of J, Ef and other combined measures of diagnostic accuracy were lower compared to those based on cut-off value derived from the TG-ROC. Results of the study indicate that the I-ELISA based on the rNp would be useful for seroepidemiological studies of RVFV infections in African buffalo.     

Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells.

The glycoprotein gB of pseudorabies virus (PrV) was expressed in various mammalian cells by a recombinant baculovirus carrying the PrV gB gene under the control of the CAG promoter. When the recombinant baculovirus was inoculated into the stable porcine kidney cell line CPK, expression of PrV gB was detected by immunofluorescent antibody analysis and a 155 kDa of protein, which has the same molecular mass as the native PrV gB, was detected by Western blotting. High levels of expression of PrV gB were observed in BHK-21, HmLu-1 and SK-H cell lines. Furthermore, anti-PrV gB-specific antibodies against PrV gB protein were detected by the enzyme-linked immunosorbent assay in mice inoculated the recombinant baculovirus. The recombinant baculovirus containing the PrV glycoprotein gB gene under the CAG promoter could be a candidate for a pseudorabies vaccine.     

Virus-like particle-based countermeasures against Rift Valley fever virus

Rift Valley fever virus (RVFV) is an arbovirus that causes significant morbidity and mortality in both humans and livestock. With increased world travel and the threat of bioterrorism, there is a real risk of RVFV spreading to na?ve geographical areas (Trans. R. Soc. Trop. Med. Hyg., 73, 1979, 618; MMWR Morb. Mortal. Wkly Rep., 49, 2000, 905). The introduction of RVFV would cause critical public health, agricultural and economic damage. Despite the clear need for an efficacious vaccine, there are no United States (US) Food and Drug Administration or US Department of Agriculture approved vaccines against RVFV. To address this need, a virus-like particle (VLP)-based vaccine candidate was developed. First, a non-replicating chimeric RVF VLP vaccine candidate was generated that protected mice and rats against a lethal RVFV challenge. This was followed by the development and optimization of conditions for production of RVF VLPs in insect and mammalian cells. Immunological studies demonstrated that VLP-based vaccine candidates elicit both humoral and cellular immune responses. Subsequent challenge studies using a lethal wild-type RVFV strain under high-containment conditions showed that RVF VLP vaccine candidates can completely protect mice and rats.     

表达小反刍兽疫病毒F蛋白的重组山羊痘病毒疫苗的研究

本研究利用gpt筛选基因和eGFP报告基因纯化筛选重组小反刍兽疫病毒(PPRV)F基因的重组山羊痘病毒(rGPV-PPRV-F),并经过PCR鉴定.免疫荧光和蛋白印迹试验都证实重组病毒能够感染绵羊羔羊睾丸细胞并表达PPRV F蛋白.以2×106PFU的rGPV-PPRV-F皮内注射免疫山羊3只,并于首次免疫后第28 d以相同剂量进行二次免疫.分别于一免后21 d和二免后14 d采血后分离血清进行病毒中和试验.结果表明,一免后21 d山羊痘病毒(GPV)中和抗体效价依次为1:40、≥1:80、≥1:80,PPRV中和抗体效价依次别为1:20、1:40、1:20,全部阳转;二免后14 d,GPV中和抗体效价≥1:80,PPRV中和抗体效价依次为1:20、1:80、1:40.本研究为小反刍兽疫重组山羊痘疫苗的产业化奠定了基础.